These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33901435)

  • 1. Imbalance between dopamine and serotonin caused by neonatal habenula lesion.
    Lee YA; Kim YJ; Lee JS; Lee S; Goto Y
    Behav Brain Res; 2021 Jul; 409():113316. PubMed ID: 33901435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of amygdala-prefrontal cortical coupling and attention deficit/hyperactivity disorder-like behaviors induced by neonatal habenula lesion: normalization by Ecklonia stolonifera extract and its active compound fucosterol.
    Kim YJ; Jeon SY; Choi JS; Kim NH; Goto Y; Lee YA
    Behav Pharmacol; 2021 Jun; 32(4):308-320. PubMed ID: 33491993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental disruption of cortico-striatal function caused by degeneration of habenula neurons.
    Lee YA; Goto Y
    PLoS One; 2011 Apr; 6(4):e19450. PubMed ID: 21559387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H3 receptor antagonists ameliorate attention deficit/hyperactivity disorder-like behavioral changes caused by neonatal habenula lesion.
    Kim YJ; Goto Y; Lee YA
    Behav Pharmacol; 2018 Feb; 29(1):71-78. PubMed ID: 28863002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and Blockade of Serotonin-4 Receptors in the Lateral Habenula Produce Antidepressant Effects in the Hemiparkinsonian Rat.
    Guo Y; Zhang L; Zhang J; Lv SX; Du CX; Wang T; Wang HS; Xie W; Liu J
    Neuropsychobiology; 2021; 80(1):52-63. PubMed ID: 32663830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral habenula 5-HT
    Tang G; Guo Y; Li R; Wang Y; Yang J; Gao S; Liu J
    Neurochem Int; 2024 Jul; 177():105766. PubMed ID: 38750961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease.
    Eskow Jaunarajs KL; George JA; Bishop C
    Neuroscience; 2012 Aug; 218():243-56. PubMed ID: 22659568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesions of the lateral habenula produce anxiolytic effects in a rat model of Parkinson's disease.
    Du CX; Guo Y; Liu J
    Neurol Res; 2021 Oct; 43(10):785-792. PubMed ID: 34081574
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation and blockade of serotonin
    Guo Y; Zhang L; Zhang J; Du CX; Lv SX; Wang T; Wang HS; Xie W; Liu J
    Neurol Res; 2019 Jul; 41(7):585-593. PubMed ID: 30929589
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.
    Nowak P; Bortel A; Dabrowska J; Oswiecimska J; Drosik M; Kwiecinski A; Opara J; Kostrzewa RM; Brus R
    Neurotox Res; 2007 Feb; 11(2):131-44. PubMed ID: 17449455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed animal model of attention deficit hyperactivity disorder.
    Kostrzewa RM; Brus R; Kalbfleisch JH; Perry KW; Fuller RW
    Brain Res Bull; 1994; 34(2):161-7. PubMed ID: 7913871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin stimulates lateral habenula via activation of the post-synaptic serotonin 2/3 receptors and transient receptor potential channels.
    Zuo W; Zhang Y; Xie G; Gregor D; Bekker A; Ye JH
    Neuropharmacology; 2016 Feb; 101():449-59. PubMed ID: 26471419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in brain area concentrations of dopamine and serotonin in Myers' High Ethanol Preferring (mHEP) and outbred rats.
    Lucas LA; McMillen BA
    J Neural Transm (Vienna); 2002 Mar; 109(3):279-92. PubMed ID: 11956951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.
    Guiard BP; El Mansari M; Merali Z; Blier P
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):625-39. PubMed ID: 18205979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.
    Yoon SY; dela Peña I; Kim SM; Woo TS; Shin CY; Son KH; Park H; Lee YS; Ryu JH; Jin M; Kim KM; Cheong JH
    Arch Pharm Res; 2013 Jan; 36(1):134-40. PubMed ID: 23371806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain.
    Inoue T; Tsuchiya K; Koyama T
    Pharmacol Biochem Behav; 1994 Dec; 49(4):911-20. PubMed ID: 7886107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder.
    Hiraide S; Ueno K; Yamaguchi T; Matsumoto M; Yanagawa Y; Yoshioka M; Togashi H
    Pharmacol Biochem Behav; 2013 Apr; 105():89-97. PubMed ID: 23380523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.